​

Funding Round

Series B - Shape Therapeutics

Series B - Shape Therapeutics

Investment Firm

Overview

A biotechnology company developing RNA technologies to shape the future of gene therapy

Announced Date

Jul 15, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Decheng Capital

Decheng Capital

Decheng Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Breton Capital Management

Breton Capital Management

Breton Capital Management is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorBreton Capital Management
Participant InvestorDecheng Capital
Participant InvestorLing Wong
Participant InvestorNew Enterprise Associates

Round Details and Background

Shape Therapeutics raised $112000000 on 2021-07-15 in Series B

A biotechnology company developing RNA technologies to shape the future of gene therapy

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 06, 2019
Series A - Shape Therapeutics
5-35.5M
Jul 15, 2021
Series B - Shape Therapeutics
6-112.0M

Recent Activity

There is no recent news or activity for this profile.